Schizophrenia Archives - Page 24 of 25

Total & Differential White Blood Cells Counts, High-Sensitivity C-Reactive Protein, & Cardiovascular Risk In Non-Affective Psychoses

Article February 13, 2017

Key Messages This study investigated whether white blood cell (WBC) counts and high-sensitivity C-reactive protein (hsCRP) levels may be linked with increased risk of cardiovascular disease in patients with schizophrenia… Read More

Auditory Dysfunction In Schizophrenia: Integrating Clinical & Basic Features

Article February 13, 2017

Key Messages The authors reviewed the mechanisms and consequences of auditory dysfunction in patients with schizophrenia. Patients with schizophrenia showed severe impairments in basic auditory processes, such as tone matching,… Read More

The Potential Of Immune Biomarkers To Advance Personalized Medicine Approaches For Schizophrenia

Article February 8, 2017

Key Messages Identifying biomarkers that can predict treatment response and/or establish diagnostic patient subpopulations may assist the development of improved treatment strategies for schizophrenia. Cytokines appear to be involved in… Read More

Pharmacokinetics: The Basics

Video January 18, 2017

During this recorded presentation, Jacquelyn Canning, PharmD, BCPP, provided a brief overview of the basics of pharmacokinetics. The presentation’s objectives included: Explain the concept and clinical relevance of pharmacokinetics Describe… Read More

An Overview Of Treatment Options & Cost For Schizophrenia

Video January 18, 2017

During this recorded presentation, Aneta Fornal, PharmD, provided a brief overview of the treatment options and cost for schizophrenia. Key points included: Prevalence and economic impact of schizophrenia Theoretical course… Read More

National Study Shows Rate Of Health Care Utilization Growth Slowed During 2003-2014; Adults With Serious Psychological Distress Are High Utilizers Of Services

Article January 13, 2017

Findings from a national study showed that, from 2003-2014, health care utilization growth rates slowed more for adults with serious mental illness (SMI) than their peers without SMI. Xiaoling Xiang,… Read More

Schizophrenia

Total & Differential White Blood Cells Counts, High-Sensitivity C-Reactive Protein, & Cardiovascular Risk In Non-Affective Psychoses

Auditory Dysfunction In Schizophrenia: Integrating Clinical & Basic Features

The Potential Of Immune Biomarkers To Advance Personalized Medicine Approaches For Schizophrenia

Pharmacokinetics: The Basics

An Overview Of Treatment Options & Cost For Schizophrenia

National Study Shows Rate Of Health Care Utilization Growth Slowed During 2003-2014; Adults With Serious Psychological Distress Are High Utilizers Of Services

Effectively Measuring The Functional Capacity Of Individuals With Serious Mental Illness

How Does Genetic Counseling Impact Individuals With Serious Mental Illness?

Detecting & Managing Cardiovascular Disease For Individuals With Serious Mental Illness

Webinar Summary – Meeting The Challenges In Caring For Patients With Schizophrenia: Roles Of The Pharmacist

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: